Furthermore, the reductions in neurological pain were associated with lower levels of the inflammation markers IL-6 and CRP as well as a lower pain interference with life activities (i.e. walking, gardening, cooking, household duties), reduction in depression symptoms and improvement in quality of sleep. The gene discussed is IL6; the disease is depressive symptom measurement.